Sonoma Pharmaceuticals
SNOA
18 hedge funds and large institutions have $1.64M invested in Sonoma Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.
250% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 2
63% more capital invested
Capital invested by funds: $1.01M → $1.64M (+$635K)
38% more funds holding
Funds holding: 13 → 18 (+5)
0.09% more ownership
Funds ownership: 0.4% → 0.49% (+0.09%)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$122K |
| 2 |
Renaissance Technologies
New York
|
+$96.2K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$86.6K |
| 4 |
HighTower Advisors
Chicago,
Illinois
|
+$77.7K |
| 5 |
Morgan Stanley
New York
|
+$19.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BA
Bard Associates
Chicago,
Illinois
|
-$2.31K |
| 2 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
-$1K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$154 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $793K | +$96.2K | +625 | +15% |
|
|
BA
2
Bard Associates
Chicago,
Illinois
| $388K | -$2.31K | -15 | -0.6% |
|
|
BCM
3
Bridgeway Capital Management
Houston,
Texas
| $133K | +$122K | +795 | New |
|
|
4
Vanguard Group
Malvern,
Pennsylvania
| $94K | +$86.6K | +563 | New |
|
|
5
HighTower Advisors
Chicago,
Illinois
| $85K | +$77.7K | +505 | New |
|
6
Acadian Asset Management
Boston,
Massachusetts
| $72K | – | – | – |
|
7
BlackRock
New York
| $29K | – | – | – |
|
|
8
Morgan Stanley
New York
| $23K | +$19.4K | +126 | +969% |
|
9
UBS Group
Zurich,
Switzerland
| $10K | +$9.08K | +59 | New |
|
|
RE
10
RBC Europe
London,
United Kingdom
| $9.31K | +$8.62K | +56 | New |
|
11
US Bancorp
Minneapolis,
Minnesota
| $4K | +$3.85K | +25 | New |
|
|
AF
12
Allworth Financial
Folsom,
California
| $1K | – | – | – |
|
13
Osaic Holdings
Scottsdale,
Arizona
| $1K | – | – | – |
|
|
PAG
14
Private Advisor Group
Morristown,
New Jersey
| – | -$1K | -7 | Closed |
|
|
15
Bank of America
Charlotte,
North Carolina
| – | -$154 | -1 | -33% |
|
16
Rockefeller Capital Management
New York
| – | +$615 | +4 | New |
|
SNOA Hedge Fund Activity: Q3 2020 in Review
18 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Sonoma Pharmaceuticals (SNOA) for Q3 2020, worth a combined $1.64M — up 63% from $1.01M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new SNOA positions and 2 closed out — a net gain of 5 holders — while 2 added to existing stakes and 2 trimmed.
The largest buyer was Bridgeway Capital Management, opening a new position worth an estimated $122K. The largest seller was Bard Associates, cutting an estimated $2.31K.
- 18 institutional investors held Sonoma Pharmaceuticals (SNOA) as of Q3 2020, up from 13 in Q2 2020.
- Funds reported $1.64M of Sonoma Pharmaceuticals stock for Q3 2020, up 63% quarter-over-quarter.
- 7 funds opened new Sonoma Pharmaceuticals positions in Q3 2020 and 2 closed out, a net change of +5 holders.
- The largest Sonoma Pharmaceuticals buyer in Q3 2020 was Bridgeway Capital Management, an estimated $122K added.
- The largest Sonoma Pharmaceuticals seller in Q3 2020 was Bard Associates, an estimated $2.31K sold.
Based on aggregated 13F filings for Q3 2020.